MedPath

GLYCOPYRROLATE

Glycopyrrolate Tablets, USP 1.5 mg

Approved
Approval ID

18ca98ed-522d-470f-bb22-908bbd7d489a

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 31, 2023

Manufacturers
FDA

FH2 Pharma LLC

DUNS: 116969558

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

GLYCOPYRROLATE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code72887-160
Application NumberANDA091522
Product Classification
M
Marketing Category
C73584
G
Generic Name
GLYCOPYRROLATE
Product Specifications
Route of AdministrationORAL
Effective DateSeptember 14, 2022
FDA Product Classification

INGREDIENTS (6)

GLYCOPYRROLATEActive
Quantity: 1.5 mg in 1 1
Code: V92SO9WP2I
Classification: ACTIB
ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMK
Classification: IACT
CALCIUM PYROPHOSPHATEInactive
Code: X69NU20D19
Classification: IACT
POVIDONE, UNSPECIFIEDInactive
Code: FZ989GH94E
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

GLYCOPYRROLATE - FDA Drug Approval Details